Association between sodium‐glucose cotransporter 2 inhibitor use and clinical outcomes in patients with type 2 diabetes after urinary tract infection
In patients with T2DM recovering from UTI, the use of SGLT2 inhibitors was associated with lower risks of mortality, kidney complications, and infection-related outcomes compared with DPP-4 inhibitors. These findings support the safety and clinical benefit of continuing or initiating SGLT2i during the post-infectious phase, even after a recent urinary tract infection.
Authors
- Ming‐Hsien Tsai (ORCID: https://orcid.org/0000-0003-3561-4689)
- Joshua Wang (ORCID: https://orcid.org/0000-0002-9458-5665)
- Chien‐Lin Lu (ORCID: https://orcid.org/0000-0002-9452-5179)
- Yu‐Wei Fang (ORCID: https://orcid.org/0000-0002-1302-1885)
- Kuo‐Cheng Lu (ORCID: https://orcid.org/0000-0002-7062-8560)
- Hsiao‐Wei Wang
Institutions
- Fu Jen Catholic University (TW)
- Taipei Tzu Chi Hospital (TW)
- Memorial Hospital (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1111/dom.70003
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Shin Kong Wu Ho-Su Memorial Hospital